NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 4 filers reported holding NEKTAR THERAPEUTICS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,540 | +79.6% | 7,626,388 | +73.5% | 0.02% | +90.0% |
| Q2 2023 | $2,528 | +471.9% | 4,396,020 | +597.5% | 0.01% | +400.0% |
| Q1 2023 | $442 | +750.0% | 630,249 | +2606.6% | 0.00% | – |
| Q4 2022 | $52 | -100.0% | 23,286 | -92.7% | 0.00% | -100.0% |
| Q2 2019 | $11,351,000 | +194.8% | 319,029 | +178.3% | 0.05% | +217.6% |
| Q1 2019 | $3,851,000 | +3082.6% | 114,635 | +3017.6% | 0.02% | +1600.0% |
| Q4 2018 | $121,000 | -81.3% | 3,677 | -65.3% | 0.00% | -66.7% |
| Q3 2018 | $646,000 | – | 10,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |